{"pmid":32408723,"title":"Conducting Research During the COVID-19 Pandemic: How Scientific Community Should be Prepared?","text":["Conducting Research During the COVID-19 Pandemic: How Scientific Community Should be Prepared?","Neurospine","Zeng, Xiang","32408723"],"journal":"Neurospine","authors":["Zeng, Xiang"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32408723","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.14245/ns.2040212.106","topics":["Prevention"],"weight":1,"_version_":1666989866090496001,"score":9.490897,"similar":[{"pmid":32463422,"title":"Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific Integrity.","text":["Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific Integrity.","JAMA","Fleming, Thomas R","Labriola, Dominic","Wittes, Janet","32463422"],"journal":"JAMA","authors":["Fleming, Thomas R","Labriola, Dominic","Wittes, Janet"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463422","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1001/jama.2020.9286","weight":0,"_version_":1668079521244381184,"score":65.17785},{"pmid":32445288,"title":"Challenges and strategies to research ethics in conducting COVID-19 research.","text":["Challenges and strategies to research ethics in conducting COVID-19 research.","The number of research involving human subjects on coronavirus disease 2019 (COVID-19) is surging, bringing challenges to the ethical review committee (ERC) in terms of reviewing speed and special ethical considerations under the pandemic. However, the existing ethical review system and regulations have their limitations to meet the demand for a prompt and efficient epidemic control. Since the research under the public health emergency is different from that carried out in familiar situations to design and implementation, the strategy for a satisfactory ERC response should balance the duty of protecting individual participants as well as the special public needs derived from the disease control. It is suggested that the ethical review-related regulations need to be updated, and a unified supervision system to the overall ERC is required. ERC collaboration, capacity-improving and efficiency-improving measures need to be taken. With respect to the reviewing guidelines, it is suggested that the international norms should be explained with more consideration of the local condition and the exceptional circumstances in this public health emergency. A joint effort needs to be taken for better research conduction.","J Evid Based Med","Ma, Xitao","Wang, Yanqiao","Gao, Tian","He, Qing","He, Yan","Yue, Rensong","You, Fengming","Tang, Jianyuan","32445288"],"abstract":["The number of research involving human subjects on coronavirus disease 2019 (COVID-19) is surging, bringing challenges to the ethical review committee (ERC) in terms of reviewing speed and special ethical considerations under the pandemic. However, the existing ethical review system and regulations have their limitations to meet the demand for a prompt and efficient epidemic control. Since the research under the public health emergency is different from that carried out in familiar situations to design and implementation, the strategy for a satisfactory ERC response should balance the duty of protecting individual participants as well as the special public needs derived from the disease control. It is suggested that the ethical review-related regulations need to be updated, and a unified supervision system to the overall ERC is required. ERC collaboration, capacity-improving and efficiency-improving measures need to be taken. With respect to the reviewing guidelines, it is suggested that the international norms should be explained with more consideration of the local condition and the exceptional circumstances in this public health emergency. A joint effort needs to be taken for better research conduction."],"journal":"J Evid Based Med","authors":["Ma, Xitao","Wang, Yanqiao","Gao, Tian","He, Qing","He, Yan","Yue, Rensong","You, Fengming","Tang, Jianyuan"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445288","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/jebm.12388","keywords":["covid-19","ethical review","informed consent","public health emergency"],"weight":0,"_version_":1667600475913977856,"score":47.765663},{"pmid":32246121,"title":"Safely conducting essential research in the face of COVID-19.","text":["Safely conducting essential research in the face of COVID-19.","Nature","Gewin, Virginia","32246121"],"journal":"Nature","authors":["Gewin, Virginia"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246121","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1038/d41586-020-01027-y","keywords":["careers","infection","therapeutics"],"weight":0,"_version_":1666138492046934019,"score":45.61985},{"pmid":32250281,"pmcid":"PMC7141248","title":"Conducting Clinical Research During the COVID-19 Pandemic: Investigator and Participant Perspectives.","text":["Conducting Clinical Research During the COVID-19 Pandemic: Investigator and Participant Perspectives.","As the medical landscape changes daily with the coronavirus disease (COVID-19) pandemic, clinical researchers are caught off-guard and are forced to make decisions on research visits in their ongoing clinical trials. Although there is some guidance from local and national organizations, the principal investigator (PI) is ultimately responsible for determining the risk-benefit ratio of conducting, rescheduling, or cancelling each research visit. The PI should take into consideration the ethical principles of research, local/national guidance, the community risk of the pandemic in their locale, staffing strain, and the risk involved to each participant, to ultimately decide on the course of action. While balancing the rights and protection of the human subject, we seldom examine patients' views and opinions about their scheduled research visit(s). This article discusses the ethical principles of beneficence and autonomy in helping the decision-making process. We discuss ways to weigh-in local and national guidance, staffing strain, and institutional support into the decision-making process and outline potential changes needed for regulatory bodies depending on the decision. Further, we discuss the need to weigh-in the individual risk-benefit ratio for each participant and present a decision tree to navigate this complex process. Finally, we examine participant and caregiver perspectives on their fears, sense of preparedness, and factors that they consider before deciding whether to keep or postpone the research appointments. This entry also provides PIs ways to support their research participants in both scenarios, including provision of psychological support.","JMIR Public Health Surveill","Padala, Prasad R","Jendro, Ashlyn M","Padala, Kalpana P","32250281"],"abstract":["As the medical landscape changes daily with the coronavirus disease (COVID-19) pandemic, clinical researchers are caught off-guard and are forced to make decisions on research visits in their ongoing clinical trials. Although there is some guidance from local and national organizations, the principal investigator (PI) is ultimately responsible for determining the risk-benefit ratio of conducting, rescheduling, or cancelling each research visit. The PI should take into consideration the ethical principles of research, local/national guidance, the community risk of the pandemic in their locale, staffing strain, and the risk involved to each participant, to ultimately decide on the course of action. While balancing the rights and protection of the human subject, we seldom examine patients' views and opinions about their scheduled research visit(s). This article discusses the ethical principles of beneficence and autonomy in helping the decision-making process. We discuss ways to weigh-in local and national guidance, staffing strain, and institutional support into the decision-making process and outline potential changes needed for regulatory bodies depending on the decision. Further, we discuss the need to weigh-in the individual risk-benefit ratio for each participant and present a decision tree to navigate this complex process. Finally, we examine participant and caregiver perspectives on their fears, sense of preparedness, and factors that they consider before deciding whether to keep or postpone the research appointments. This entry also provides PIs ways to support their research participants in both scenarios, including provision of psychological support."],"journal":"JMIR Public Health Surveill","authors":["Padala, Prasad R","Jendro, Ashlyn M","Padala, Kalpana P"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32250281","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.2196/18887","keywords":["covid-19","clinical research","ethics","infectious disease","outbreak","pandemic","public health"],"weight":0,"_version_":1666138491030863872,"score":43.591087},{"pmid":32310914,"title":"[SARS-CoV-2 and the scientific community].","text":["[SARS-CoV-2 and the scientific community].","G Ital Cardiol (Rome)","Di Pasquale, Giuseppe","32310914"],"journal":"G Ital Cardiol (Rome)","authors":["Di Pasquale, Giuseppe"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32310914","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1714/3343.33126","link_comment_for":"31978945","weight":0,"_version_":1666138491266793472,"score":43.039658}]}